• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 04-11-2025: Press Release

    04-11-2025 | 02:41 pm

    Alembic Pharma reported strong Q2 FY26 results: Revenue surged 16% to Rs.1,910 Cr, and PAT climbed 20% to Rs.185 Cr. US Generics grew 21%, Ex-US 31%, and India Branded 5%. The company also acquired Utility Therapeutics, entering the US branded drug market.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited